Patients who test positive for SARS-CoV-2 more likely to be Hispanic, report Spanish as primary language
Surprise Medical Bills Could Be Reduced by COVID-19 Relief Package
Main provisions of the legislation would take effect January 2022
Poll: Pandemic-Related Concerns Top of Mind for Parents
While the virus itself is not a top concern overall, impacts of COVID-19, including screen time and mental health, rate highly
Care Rationing Being Considered by California Hospitals
California has more than twice as many hospitalized COVID-19 patients as it did at its previous peak in July
Buprenorphine Rx Fills for OUD Plateau During Pandemic
Cash-paid prescriptions declined significantly, but no significant changes seen in those paid by public or private insurance
European Union Approves Pfizer COVID-19 Vaccine
Vaccine is already being given to high-risk people in the United States and Britain
Are COVID-19 Vaccinations Mandatory for Texas Schoolchildren?
'Will this COVID-19 shot be required for Texas schoolchildren,' was the headline of an article published by DallasNews.com on December 21, 2020.
In response to this headline, Texas Governor Gregg Abbott quickly posted on Twitter: 'No. In Texas, vaccines are always voluntary.'
3 in 1 Combination COVID-19 Therapeutic Launches Late-Stage Study
A Massachusetts-based biopharmaceutical company announced that the U.S. Food and Drug Administrations (FDA) had approved the Company’s Investigational New Drug (IND) application to proceed with initiation of Phase 2 clinical trial of Brilacidin in hospitalized patients with COVID-19.
Brilacidin is a Host Defense Protein (HDP) mimetic representing a new class of drug with antiviral, anti-inflammatory, and anti-bacterial properties, said Innovation Pharmaceuticals.
Low U.S. Flu Rates Seen as Pandemic Rages
Many more people are getting flu shots to avoid the risk for getting both the flu and COVID-19
Long-Term Care Workers Often Hold Multiple Jobs
Movements from first to second jobs, often in health care or other essential work, may spread COVID-19